Sotera Health (SHC) Cost of Revenue (2020 - 2026)

Sotera Health has reported Cost of Revenue for 7 years, with the latest figure at $143.4 million in Q2 2026.

• On a quarterly basis, Cost of Revenue rose 12.29% year-over-year to $143.4 million in Q2 2026; TTM through Jun 2026 was $547.7 million, a 9.51% increase from a year earlier, with the FY2025 full-year figure at $518.1 million, up 4.0% from the prior year.
• Cost of Revenue was $143.4 million for Q2 2026 at Sotera Health, up from $133.0 million in the prior quarter.
• The five-year high for Cost of Revenue was $143.4 million in Q2 2026, with the low at $107.9 million in Q1 2022.
• Average Cost of Revenue over 5 years is $122.9 million, with a median of $122.4 million recorded in 2024.
• The sharpest annual moves came in 2023 and 2024: Cost of Revenue climbed 18.46% in 2023, then declined 3.32% in 2024.
• Over 5 years, Cost of Revenue stood at $109.9 million in 2022, then increased by 18.46% to $130.2 million in 2023, then declined by 3.32% to $125.8 million in 2024, then grew by 9.28% to $137.5 million in 2025, then increased by 4.28% to $143.4 million in 2026.
• The last three Cost of Revenue figures came in at $143.4 million (Q2 2026), $133.0 million (Q1 2026), and $137.5 million (Q4 2025), per Business Quant data.